STOCK TITAN

MFA Financial, Inc. Form 4 Filings

MFA NYSE

Every Form 4 that MFA Financial, Inc. (MFA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow MFA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MFA filings page.

Rhea-AI Summary

Wald Richard C. reported acquisition or exercise transactions in this Form 4 filing.

MFA Financial director Richard C. Wald received a grant of 16,448 restricted stock units. Each unit represents one share of MFA common stock and was fully vested on the grant date. The units will be settled in an equal number of shares upon his board service ending or on or about January 15, 2032. Following this award, Wald directly holds 94,703 shares-linked units.

Rhea-AI Summary

Goodman Laurie reported acquisition or exercise transactions in this Form 4 filing.

MFA Financial, Inc. director Laurie Goodman received a grant of 29,057 Restricted Stock Units (RSUs), each representing one share of MFA common stock. The RSUs were fully vested at grant and will be settled in the same number of common shares.

Settlement will occur on the earlier of her termination of service as a director or on or about January 15, 2032, except in certain circumstances. Following this award, she holds 169,448 RSUs directly, highlighting a continued equity-based compensation position rather than an open-market share purchase or sale.

Rhea-AI Summary

JOSEPHS ROBIN reported acquisition or exercise transactions in this Form 4 filing.

MFA Financial director Robin Josephs received a grant of 16,448 restricted stock units (RSUs) tied to MFA common stock. Each RSU represents the right to receive one share of common stock. The award was fully vested on the grant date and will be settled in shares.

The RSUs will be settled in an equivalent number of MFA common shares upon the earlier of Josephs’ termination of service as a director or on or about January 15, 2032. Following this grant, Josephs holds 109,238 derivative securities linked to MFA common stock directly.

Rhea-AI Summary

POLSKY LISA reported acquisition or exercise transactions in this Form 4 filing.

MFA Financial director Lisa Polsky received a grant of 16,448 restricted stock units (RSUs). Each RSU represents one share of MFA Financial, Inc. common stock and was granted at no cash cost to her. The RSUs were fully vested on the grant date.

The award will be settled in an equivalent number of MFA common shares on the earlier of her termination of service as a director or on or about January 15, 2032, except in certain circumstances. Following this grant, her directly held position reported in this filing is 94,703 shares.

Rhea-AI Summary

Small Christopher R. reported acquisition or exercise transactions in this Form 4 filing.

MFA Financial, Inc. director Christopher R. Small received a grant of 16,448 restricted stock units on common stock as compensation. The award was granted at $0.00 per unit and increased his directly held restricted stock units to 32,288 following the transaction.

Each restricted stock unit represents the right to receive one share of MFA common stock. The units were fully vested on the grant date and will be settled in an equivalent number of common shares upon the earlier of his termination of service as a director or on or about January 15, 2032.

Rhea-AI Summary

Stamps Sheila A reported acquisition or exercise transactions in this Form 4 filing.

MFA Financial, Inc. director Sheila A. Stamps received a grant of restricted stock units as part of her equity compensation. She was awarded 16,448 restricted stock unitsJune 8, 2026, with each unit representing one share of MFA common stock.

The units were fully vested on the grant date and will be settled in an equivalent number of common shares. Settlement will occur on the earlier of her termination of service as a director or on or about January 15, 2032, except in certain specified circumstances. Following this award, she directly holds 54,720 restricted stock units.

Rhea-AI Summary

MFA Financial director Robin Josephs reported a routine equity award settlement. On 01/15/2026, 3,473 restricted stock units granted in 2016 and deferred under the MFA Financial, Inc. 2003 Non-Employee Directors' Deferred Compensation Plan were settled in 3,473 shares of common stock, at a reported price of $0.00 per share, reflecting the conversion of previously earned phantom stock into actual shares.

After this transaction, Josephs directly held 35,454 shares of MFA Financial common stock and 92,790 restricted stock units, each RSU being the economic equivalent of one share of common stock.

Rhea-AI Summary

MFA Financial, Inc. director Laurie Goodman reported a routine equity compensation settlement. On 01/15/2026, 3,473 restricted stock units granted in 2016 were settled, with each unit converting into one share of MFA Financial common stock at an exercise price of $0.00 under a deferred compensation plan. Following this transaction, Goodman directly owned 9,480 shares of common stock and 140,391 derivative securities in the form of restricted stock units. These RSUs were previously fully vested phantom shares economically equivalent to MFA Financial common stock.

Rhea-AI Summary

MFA Financial President and Chief Investment Officer Bryan Wulfsohn reported multiple equity award transactions dated January 8, 2026. He acquired 67,914 shares of common stock from the settlement of time-based restricted stock units and 232,090 shares tied to performance-based restricted stock units, all at an exercise price of $0 per share as they are phantom share awards.

The filing shows share surrenders of 35,432 and 13,339 common shares at $9.57 per share to satisfy tax obligations arising from these settlements. The performance-based units were granted in January 2023, vesting based on total stockholder return over the three years ended December 31, 2025, with vested PRSUs and related dividend-equivalent units scheduled to settle in common stock in January 2027. The number of shares beneficially owned was also reduced to reflect liquidation of 819 shares previously held in the company’s 401(k) plan after MFA stock was removed as an investment option.

Rhea-AI Summary

MFA Financial, Inc. senior vice president and co-controller Natasha Seemungal reported multiple equity award transactions on common stock and phantom share units. On January 8, 2026, time-based restricted stock units converted into 4,922 shares of common stock, and performance-based restricted stock units tied to three-year total shareholder return contributed an additional 16,823 shares, increasing her directly held common stock to 33,826 shares before tax withholding.

To cover tax obligations from these settlements, she surrendered 2,266 shares and 1,470 shares of common stock at a price of $9.57 per share, leaving 30,090 shares of common stock held directly. Corresponding phantom share awards in the form of TRSUs and PRSUs were reduced by 4,922 and 9,434 phantom shares, with vested PRSUs, including dividend-equivalent units, scheduled to settle in common stock in January 2027.

Rhea-AI Summary

MFA Financial, Inc. insider Harold E. Schwartz, a Senior Vice President, reported equity compensation activity on January 8, 2026. He acquired 26,575 shares of common stock from the settlement of time-based restricted stock units (TRSUs) and an additional 90,821 shares of common stock tied to performance-based restricted stock units (PRSUs), both economically equivalent to common shares.

To cover tax obligations from these settlements, Schwartz surrendered 15,465 shares and 5,582 shares of common stock at a price of $9.57 per share. Following these transactions, he beneficially owned 159,518 shares of MFA common stock. The PRSUs, including 28,420 units from dividend equivalents, are scheduled to settle in January 2027 as one share of common stock for each vested phantom share, based on MFA’s total stockholder return over the three years ended December 31, 2025.

Rhea-AI Summary

MFA Financial, Inc. executive Lori R. Samuels, SVP & Chief Loan Operations Officer, reported equity award activity involving company stock and phantom shares. On January 8, 2026, 15,749 time-based restricted stock units (TRSUs) settled into the same number of common shares, and performance-based RSUs (PRSUs) granted in January 2023 vested, representing 53,827 common shares, including 16,848 units tied to dividend equivalents. The vested PRSUs are scheduled to settle in January 2027, with each phantom share converting into one common share. To cover tax obligations from these settlements, 9,479 and 3,461 common shares were surrendered at a price of $9.57 per share. Following these transactions, Samuels continues to hold common stock and phantom share balances as reflected in the tables.

Rhea-AI Summary

MFA Financial senior vice president and chief financial officer Michael C. Roper reported multiple equity award settlements and related tax share surrenders on January 8, 2026. Time-based restricted stock units (TRSUs), structured as phantom shares granted in January 2023, settled into 15,749 shares of common stock at $0 per share. Performance-based restricted stock units (PRSUs) granted at the same time vested into 53,827 shares, including additional PRSUs credited for dividend equivalents over the three-year performance period ended December 31, 2025.

To cover tax obligations from these settlements, Roper surrendered 8,810 shares and 3,217 shares of common stock at $9.57 per share. Following the reported transactions, he held 88,138 shares of MFA common stock directly, along with substantial remaining phantom share balances. A prior change to MFA’s 401(k) plan eliminated MFA stock as an investment option, reducing his beneficial ownership by 1,000 shares previously held in that plan.

Rhea-AI Summary

MFA Financial, Inc. senior vice president and co-controller Mei Lin reported the vesting and settlement of stock-based awards granted in January 2023. On January 8, 2026, 4,922 time-based restricted stock units and 16,823 performance-based restricted stock units, structured as phantom shares, were converted into common stock at an exercise price of $0 per share. Phantom shares are described as economically equivalent to one share of MFA common stock and settle share-for-share.

To cover tax obligations from these settlements, Lin surrendered 2,057 and 1,335 common shares at a price of $9.57 per share. Following these transactions, Lin directly held 32,131 common shares. In the derivative holdings, 4,922 and 9,434 phantom shares were settled, leaving 51,968 and 42,534 phantom shares outstanding in two award lines. The performance-based awards vested based on MFA’s total stockholder return for the three years ended December 31, 2025, and vested PRSUs, including 5,268 units from dividend equivalents, are scheduled to settle in common stock in January 2027.

Rhea-AI Summary

MFA Financial CEO Craig L. Knutson, who also serves as a director, reported several equity award-related transactions dated January 8, 2026. He acquired 157,481 shares of common stock upon settlement of time-based restricted stock units granted in January 2023 and 538,186 shares of common stock tied to performance-based restricted stock units from the same grant.

Phantom shares used in these awards are each the economic equivalent of one share of MFA common stock and settle one-for-one in stock. The filing shows share dispositions of 81,087 shares and 42,127 shares at $9.57 per share, representing shares surrendered to cover tax obligations on the equity settlements. The company also previously eliminated MFA common stock as an investment option in its 401(k) plan, reducing Knutson’s reported beneficial ownership by 14,710 shares. Certain vested performance-based units, including dividend-equivalent units, are scheduled to settle in stock in January 2027.

Rhea-AI Summary

MFA Financial, Inc. reported equity awards for a senior vice president and Chief Loan Operations Officer on 01/02/2026. The officer received 27,283 phantom shares that are scheduled to vest on December 31, 2028 and then be settled in an equal number of common shares within 30 days after vesting.

The officer also received 42,245 performance-based phantom shares as a target award. The actual number of common shares delivered at vesting may range from 0% to 200% of this target, based on MFA’s absolute total stockholder return and its return relative to a designated peer group over a three-year period, with vesting generally on December 31, 2028 and settlement in common stock in January 2030. Dividends paid during the vesting period will adjust the number of phantom shares that ultimately vest.

Rhea-AI Summary

MFA Financial, Inc. reported an equity award to a senior executive in a Form 4 filing. On 01/02/2026, an officer serving as Sr VP & Chief Accounting Officer received two types of phantom share awards tied to MFA common stock.

The officer was granted 8,815 phantom shares that are scheduled to vest, subject to forfeiture, on December 31, 2028 and then be settled in the same number of MFA common shares within 30 days after vesting. Each phantom share represents the right to receive one share of common stock.

The filing also reports 13,649 performance-based phantom shares, described as a target award. The actual shares earned can range from 0% to 200% of this target, based on MFA’s absolute total stockholder return and its total stockholder return versus a designated peer group over a three-year period ending around the vesting date. These performance-based phantom shares are expected to vest generally on December 31, 2028, with settlement in MFA common stock in January 2030, adjusted for the value of dividends during the vesting period.

Rhea-AI Summary

MFA Financial, Inc. reported an equity award for its Chief Executive Officer and director on a Form 4 dated 01/02/2026. The filing shows grants of phantom shares, which each represent the right to receive one share of MFA common stock.

The CEO received 176,916 time-based phantom shares that are scheduled to vest on December 31, 2028, subject to forfeiture, and to be settled in an equivalent number of MFA common shares within 30 days after vesting. In addition, the CEO received 273,938 performance-based phantom shares, representing a target amount. The actual number of shares earned can range from 0% to 200% of this target, based on MFA’s absolute total stockholder return and its return relative to a designated peer group over a three-year period.

The performance-based phantom shares are generally expected to vest on December 31, 2028, after certification of performance, with settlement in MFA common stock in January 2030, adjusted for the value of dividends paid during the vesting period on the shares that ultimately vest.

Rhea-AI Summary

MFA Financial reported an equity compensation grant to a senior executive. On 01/02/2026, a Sr. VP & Co-Controller received two awards of phantom shares, each representing the right to receive one share of MFA common stock.

The first award covers 6,296 phantom shares that are scheduled to vest, subject to forfeiture, on December 31, 2028 and then be settled in the same number of MFA shares within 30 days after vesting. The second is a performance-based grant with a target of 9,750 phantom shares at a price of $0.

For the performance award, the actual number of MFA shares ultimately delivered can range from 0% to 200% of the target, based on MFA’s absolute total stockholder return and its total stockholder return versus a designated peer group over a three-year period. These performance-based phantom shares are expected to vest generally on December 31, 2028, with settlement in MFA common stock in January 2030, adjusted for dividends paid during the vesting period.

Rhea-AI Summary

MFA Financial, Inc. reported that a senior executive, serving as Sr. VP & Co-Controller, received new equity-based awards in the form of phantom shares on January 2, 2026. The filing shows two grants of derivative securities tied to MFA common stock.

The first grant is 6,296 phantom shares, which are scheduled to vest on December 31, 2028, subject to forfeiture, and then be settled in an equivalent number of MFA common shares within 30 days after vesting. The second grant is 9,750 performance-based phantom shares, representing a target amount that can range from 0% to 200% of this figure based on MFA’s absolute total shareholder return and its return versus a designated peer group over a three-year period. These performance-based awards generally vest around December 31, 2028 upon certification of results and will be settled in MFA common stock in January 2030, with adjustments for dividends during the vesting period.

Rhea-AI Summary

MFA Financial, Inc. disclosed that Senior Vice President Harold E. Schwartz received new phantom share awards tied to MFA common stock. On 01/02/2026, he acquired 32,529 phantom shares that vest, subject to forfeiture, on December 31, 2028, and are then settled in an equivalent number of MFA shares within 30 days after vesting.

He also received a performance-based grant of 50,369 phantom shares, representing the target award. The ultimate payout can range from 0% to 200% of this target based on MFA’s absolute total stockholder return (TSR) and TSR relative to a peer group over a three‑year period, with vesting expected around December 31, 2028 and settlement in shares in January 2030. Following these grants, Schwartz beneficially owns 300,061 phantom share units directly.

Rhea-AI Summary

MFA Financial, Inc. reported new equity awards for its Senior Vice President and Chief Financial Officer on January 2, 2026. The filing shows grants of phantom shares, which each represent the right to receive one share of MFA common stock.

One grant covers 37,776 phantom shares that are scheduled to vest, subject to forfeiture, on December 31, 2028, and then be settled in an equivalent number of MFA common shares within 30 days after vesting. A second grant covers 58,492 performance-based phantom shares, representing a target award that can ultimately range from 0% to 200% of that amount depending on achievement of a pre-set performance metric.

The performance-based phantom shares are designed to vest generally on December 31, 2028, after the Compensation Committee certifies performance based on MFA’s absolute total stockholder return and its total stockholder return versus a designated peer group over a three-year period. These awards will be adjusted for dividends paid during the vesting period and are expected to be settled in MFA common stock in January 2030.

Rhea-AI Summary

MFA Financial, Inc. reported equity awards to its President and Chief Investment Officer on 01/02/2026 in the form of phantom shares. One grant covers 100,735 phantom shares, each representing the right to receive one share of MFA common stock, scheduled to vest on December 31, 2028 and be settled in shares within 30 days after vesting. A second, performance-based grant covers a target 155,979 phantom shares, with the actual number earned ranging from 0% to 200% of target based on pre-set performance metrics. Vesting for the performance award is generally tied to MFA’s absolute total shareholder return and relative total shareholder return versus a peer group over three years, with settlement in MFA common stock in January 2030.

Rhea-AI Summary

Mei Lin, Sr. VP & Co-Controller of MFA Financial, Inc. (MFAO) reported a sale of 2,775 shares of MFA common stock on 09/15/2025 at a reported price of $10.10 per share. After the transaction she beneficially owned 10,778 shares in a direct capacity. The Form 4 is signed and dated 09/16/2025 and discloses a routine officer sale.